Cargando…

The Impact of International Nonproprietary Names Integration on Prescribing Reimbursement Medicines for Arterial Hypertension and Analysis of Medication Errors in Latvia

The use of international nonproprietary names (INNs) has been mandatory for prescriptions of state-reimbursed drugs in Latvia since 1 April 2020. In a retrospective analysis, we aimed to examine the impact of the new regulation on changes in the prescribing and dispensing practice of antihypertensiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gavrilova, Anna, Zolovs, Maksims, Latkovskis, Gustavs, Urtāne, Inga
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9408624/ https://www.ncbi.nlm.nih.gov/pubmed/36011791 http://dx.doi.org/10.3390/ijerph191610156

Ejemplares similares

National Trends in the Use of State-Reimbursed Lipid-Lowering Medications in Latvia (2012–2021)
por: Praskilevics, Arturs, et al.
Publicado: (2023)

Stability of Direct Oral Anticoagulants Concentrations in Blood Samples for Accessibility Expansion of Chromogenic Assays
por: Gavrilova, Anna, et al.
Publicado: (2023)

The INNs and outs of antibody nonproprietary names
por: Jones, Tim D., et al.
Publicado: (2015)

International nonproprietary names for monoclonal antibodies: an evolving nomenclature system
por: Guimaraes Koch, Sofia S., et al.
Publicado: (2022)

Patient Safety in Medication Nomenclature: Orthographic and Semantic Properties of International Nonproprietary Names
por: Bryan, Rachel, et al.
Publicado: (2015)

International Nonproprietary Names (INN) for novel vaccine substances: A matter of safety
por: Robertson, James S., et al.
Publicado: (2022)

Changes to International Nonproprietary Names for antibody therapeutics 2017 and beyond: of mice, men and more
por: Parren, Paul W. H. I., et al.
Publicado: (2017)

Systematic analysis of the varied designs of 819 therapeutic antibodies and Fc fusion proteins assigned international nonproprietary names
por: Wilkinson, Ian, et al.
Publicado: (2022)

International nonproprietary names (INN) for pharmaceuticals substances : lists 1-73 of proposed INN and lists 1-35 of recomended INN cumulative list No. 9 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-73 de DCI proposées et listes 1-35 de DCI recommandées liste récapitulative No. 9
Publicado: (1996)

International nonproprietary names (INN) for pharmaceutical substances, : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques, listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Publicado: (1992)

International nonproprietary names (INN) for pharmaceutical substances : lists 1-65 of proposed INN and lists 1-31 of recommended INN : cumulative list no. 8 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques : listes 1-65 de DCI proposées et listes 1-31 de DCI recommandées : liste récapitulative no. 8.
Publicado: (1992)

The harmonization of World Health Organization International Nonproprietary Names definitions for cell and cell-based gene therapy substances: when a name is not enough
por: Loizides, Ursula, et al.
Publicado: (2021)

International nonproprietary names (INN) for pharmaceutical substances, 1988 : lists 1-58 of proposed INN and lists 1-27 of recommended INN : cumulative list no. 7 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques, 1988 : listes 1-58 de DCI proposées et listes 1-27 de DCI recommandées : liste récapitulative no. 7.
Publicado: (1988)

International nonproprietary names (INN) for pharmaceutical substances, 1982 : lists 1-47 of proposed INN and lists 1-21 of recommended INN : cumulative list no. 6 = Dénominations communes internationales (DCI) pour les substances pharmaceutiques, 1982 : listes 1-47 de DCI proposées et listes 1-21 de DCI recommandées : liste récapitulative no. 6.
Publicado: (1982)

Nomenclature and Traceability Debate for Biosimilars: Small-Molecule Surrogates Lend Support for Distinguishable Nonproprietary Names
por: Chao, Jingdong, et al.
Publicado: (2015)

Clinical implications for substandard, nonproprietary medicines in multiple sclerosis: focus on fingolimod
por: Correale, Jorge, et al.
Publicado: (2016)

Anxiety Screening among the General Population of Latvia and Associated Factors
por: Vinogradova, Vineta Viktorija, et al.
Publicado: (2022)

Impact of the flour of Jerusalem artichoke on the production of methane and carbon dioxide and growth performance in calves
por: Jonova, Sintija, et al.
Publicado: (2018)

Impact of educational training and C-reactive protein point-of-care testing on antibiotic prescribing in rural and urban family physician practices in Latvia: a randomised controlled intervention study
por: Likopa, Zane, et al.
Publicado: (2022)

Prevalence and associated factors of obsessive-compulsive disorder among the general population of Latvia
por: Vinogradova, V., et al.
Publicado: (2023)

Tissue-Welding Device: Considerable Advantages for Spleen Surgery Based on Histological and Cardiorespiratory Investigation
por: Gatiņa, Linda, et al.
Publicado: (2022)

Adherence Level to Arterial Hypertension Treatment: A Cross-Sectional Patient Survey and Retrospective Analysis of the NHS Prescription Database
por: Gavrilova, Anna, et al.
Publicado: (2021)

Cervical cancer screening attendance related factors among women in Latvia
por: Springe, L, et al.
Publicado: (2023)

Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia
por: Vrublevska, Jelena, et al.
Publicado: (2022)

Self-reported suicidal behaviours and associated factors in the general population of Latvia (2010–2018)
por: Mieze, Krista, et al.
Publicado: (2023)

Knowledge about Disease, Medication Therapy, and Related Medication Adherence Levels among Patients with Hypertension
por: Gavrilova, Anna, et al.
Publicado: (2019)

Prevalence and associated factors of mental disorders in the nationwide primary care population in Latvia: a cross-sectional study
por: Rancans, Elmars, et al.
Publicado: (2020)

Parity of Calving Influences the Likelihood of Calves Having Cryptosporidium spp.
por: Zolova, Alīna, et al.
Publicado: (2022)

Prevalence of susceptibility to Cryptosporidium spp. among dairy calves with different feeding regimens with an emphasis on the feeding of transition milk
por: Zolova, Alīna, et al.
Publicado: (2022)

Exploring the Mediating Role of Parental Anxiety in the Link between Children’s Mental Health and Glycemic Control in Type 1 Diabetes
por: Silina, Evija, et al.
Publicado: (2023)

Pulmonary arterial hypertension incidence in Latvia in 2019
por: Kaulins, Ricards, et al.
Publicado: (2022)

Latvia /
Publicado: (2001)

Suicidality and Its Relation with Physical and Mental Conditions: Results from a Cross-Sectional Study of the Nationwide Primary Care Population Sample in Latvia
por: Renemane, Lubova, et al.
Publicado: (2021)

Inborn Errors of Immunity in Latvia: Analysis of Data from 1994 to 2020
por: Prokofjeva, Tatjana, et al.
Publicado: (2022)

Sequences for reporting on mild and serious types of suicidal behaviours: A population-based study in Latvia in 2010-2018
por: Mieze, K., et al.
Publicado: (2022)

Error in Author Name
Publicado: (2019)

Error in Author’s Name
Publicado: (2021)

Error in Author’s Name
Publicado: (2022)

Error in Author Name
Publicado: (2022)

Error in Author Name
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pluaq8ramgcll6k75n127kj6be